Difference between revisions of "Transcutaneous Electric Nerve Stimulation"

Line 1: Line 1:
== Introduzione==


{{main menu}}{{ArtBy|
| autore = Gianni Frisardi
| autore2 =
| autore3 =
}}


In questo capitolo prendiamo in considerazione un altro argomento molto dibattuto, quello della Stimolazione Elettrica Transcutanea (TENS), su cui ancora non c'è una opinione univoca nella Comunità Scientifica Internazionale. Questa premessa viene confermata dal fatto che nonostante lo Research Diagnostic Criteria (RDC) abbia categoricamente invalidato la procedura clinica nella diagnostica dei pazienti affetti da Disordini Temporomandibolari, ancora viene considerata valida, visto che se ne parla, si pubblicano articoli ma sostanzialmente si pratica ancora come procedura clinica. Questo controsenso può essere verificato da lavori scientifici in letteratura con conclusioni intermedie ed ambigue che generano di conseguenza solo domande e non conclusioni valide.
==Introduction==
 
In this chapter, we consider another highly debated topic: Transcutaneous Electrical Nerve Stimulation (TENS), on which there is still no unanimous opinion within the International Scientific Community. This premise is confirmed by the fact that, although the Research Diagnostic Criteria (RDC) have categorically invalidated the clinical procedure in diagnosing patients with Temporomandibular Disorders, the procedure is still considered valid. It continues to be discussed, articles are published, and it is still practiced. This inconsistency is demonstrated by scientific papers in the literature with intermediate and ambiguous conclusions, which generate only questions without providing valid answers.
 
The RDC has clinically deemed the TENS procedure invalid based on the freeway space and myocentric trajectory, both as diagnostic elements for Temporomandibular Disorders (TMD) and as part of masticatory prosthetic rehabilitation treatment. As can be seen from the specific section of Table 1 presented in the chapter [[Research Diagnostic Criteria (RDC)]], it is clear that both freeway space and TENS trajectory were excluded due to a low predictive value (PPV: 0.17). While this might be true, it is essential to delve into the technical and methodological details to understand the rationale behind this decision. For this reason, we will briefly but thoroughly describe the TENS method to better understand its weaknesses and strengths.


Sostanzialmente lo RDC ha considerato non valido clinicamente la procedura con TENS sulla base del free way space e della traiettoria della miocentrica che sia come elemento di diagnosi nei Disordini Temporomandibolare che per il trattamento delle riabilitazioni protesiche masticatorie. Come si può notare dallo specifica sezione della tabella 1 presentata nel capitolo Stimolazione Elettrica Transcutanea si evince che sia il fre way space che la traiettoria con TENS siano state escluse per un valore predittivo troppo basso. Tutto questo potrebbe essere anche vero ma è essenziale scendere in profondità tecniche e metodologiche per capire quanto c'è di vero e di giustificabile in certe prese di posizioni oppure se è solo un modo non corretto di impiegare il metodo. Per questo motivo è auspicabile in primis descrivere brevemente ma dettagliatamente il metodo TENS e poi capire quali sono i punti deboli e forza della metodica.
{| class="wikitable"
{| class="wikitable"
| colspan="5" |'''Table 1:''' DTM diagnostic methodologies analyzed and eliminated from the DRC because they are not scientifically validated
| colspan="5" |'''Table 1:''' TMD diagnostic methodologies analyzed and excluded by the DRC due to lack of scientific validation
|-
|-
|'''Diagnostic Tests'''
|'''Diagnostic Tests'''
Line 12: Line 19:
|'''Sensitivity'''
|'''Sensitivity'''
|'''Specificity'''
|'''Specificity'''
|'''VPP'''
|'''PPV'''
|-
|-
| colspan="5" |'''Electrical stimulation methods'''
| colspan="5" |'''Electrical stimulation methods'''  
|-
|-
|Free rest space before stimulation''( Cooper e Rabuzzi 1984)''<ref name=":1">BC Cooper, D D Rabuzzi. Myofacial pain dysfunction syndrome: a clinical study of asymptomatic subjects. Laryngoscope. 1984 Jan;94(1):68-75. doi: 10.1002/lary.5540940116.
|Free rest space before stimulation ''(Cooper and Rabuzzi 1984)''<ref name=":1">BC Cooper, D D Rabuzzi. Myofacial pain dysfunction syndrome: a clinical study of asymptomatic subjects. Laryngoscope. 1984 Jan;94(1):68-75. doi: 10.1002/lary.5540940116.</ref>
</ref>
|0.75-2.0 mm
|0.75-2.0 mm
| 0.42
|0.42
| 0.62
|0.62
|0.17
|0.17
|-
|-
|Free space to rest after electric-stimulation ''( Cooper e Rabuzzi 1984;''<ref name=":1" />)
|Free rest space after electrical stimulation ''(Cooper and Rabuzzi 1984)''<ref name=":1" />
|0.75-2.0 mm
|0.75-2.0 mm
|0.76
|0.76
Line 29: Line 35:
|0.11
|0.11
|-
|-
|Closure trajectory before after electrical stimulation''( Cooper e Rabuzzi 1984)''<ref name=":1" />
|Closure trajectory before and after electrical stimulation ''(Cooper and Rabuzzi 1984)''<ref name=":1" />
|Non definita
|Undefined
|0.75
|0.75  
|0.27  
|0.27
| 0.12
| 0.12
|-
|-
| colspan="5" |<small>Cutoff: Parameters and limits of significance that should divide sick from healthy, for each test reported</small><small>Sensitivity: Ability of the specified test to identify the truly sick in a sample of healthy and sick subjects</small>
| colspan="5" |<small>Cutoff: Parameters and significance limits used to separate healthy from sick subjects for each reported test.</small><small>Sensitivity: The ability of the specified test to identify truly sick subjects in a mixed sample of healthy and sick subjects.</small><small>Specificity: The ability of the specified test to identify healthy subjects in a mixed sample of healthy and sick subjects.</small><small>Positive Predictive Value (PPV): The ratio of the specified test’s ability to identify truly sick patients to the total sick population in a mixed sample of healthy and sick subjects.</small>
 
<small>Specificity: Ability of the specified test to identify the healthy  in a sample of healthy and sick subjects</small>
 
<small>Positive Predictive Value (PPV): Ratio of the ability of the specified test to identify truly sick (positive) patients on the total sick population in a sample of healthy and sick subjects.</small>
|}
|}


===TENS e Disordini Temporomandibolari===
=== TENS and Temporomandibular Disorders===
L'articolazione temporo-mandibolare (TMJ) è un'articolazione a cerniera con proprietà biartrodiali, che consente i movimenti complessi richiesti per la masticazione<ref>Okoje VN, Aladelusi TO, Abimbola TA. Managing temporomandibular joint dislocation in ibadan: a review of 11 cases. Ann Ib Postgrad Med 2017;15:96-10</ref>. Il disturbo temporo-mandibolare (TMD) si verifica quando la TMJ e le strutture anatomiche associate sono colpite<ref>Maini K, Dua A. Temporomandibular Syndrome. Treasure Island, FL: StatPearls Publishing; 2024</ref><ref>Murphy MK, MacBarb RF, Wong ME, Athanasiou KA. Temporomandibular disorders: a review of etiology, clinical management, and tissue engineering strategies. Int J Oral Maxillofac Implants 2013;28:e393-414. doi: 10.11607/jomi.te20</ref>. Circa il 25% degli individui a livello globale mostra segni o sintomi di TMD<ref>Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-92. doi: 10.1159/000047881</ref>. Inoltre, i TMD si verificano 1,5-2,5 volte più frequentemente nelle donne rispetto agli uomini<ref>Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-92. doi: 10.1159/000047881</ref>. Si tratta di un disturbo prevalente, caratterizzato da dolore, disfunzione e disagio nella TMJ e nelle strutture circostanti, che influisce su una parte significativa della popolazione, limitando le attività quotidiane, riducendo la qualità della vita e aumentando i costi sanitari<ref>Kapos FP, Exposto FG, Oyarzo JF, Durham J. Temporomandibular disorders: a review of current concepts in aetiology, diagnosis and management. Oral Surg 2020;13:321-34. doi: 10.1111/ors.12473</ref><ref>Alrizqi AH, Aleissa BM. Prevalence of Temporomandibular Disorders Between 2015-2021: A Literature Review. Cureus 2023;15:e37028. doi: 10.7759/cureus.37028</ref>.
The temporomandibular joint (TMJ) is a hinge joint with biarticular properties, enabling the complex movements required for chewing<ref>Okoje VN, Aladelusi TO, Abimbola TA. Managing temporomandibular joint dislocation in ibadan: a review of 11 cases. Ann Ib Postgrad Med 2017;15:96-10.</ref>. Temporomandibular disorder (TMD) occurs when the TMJ and associated anatomical structures are affected<ref>Maini K, Dua A. Temporomandibular Syndrome. Treasure Island, FL: StatPearls Publishing; 2024.</ref><ref>Murphy MK, MacBarb RF, Wong ME, Athanasiou KA. Temporomandibular disorders: a review of etiology, clinical management, and tissue engineering strategies. Int J Oral Maxillofac Implants 2013;28:e393-414. doi: 10.11607/jomi.te20.</ref>. Approximately 25% of individuals worldwide show signs or symptoms of TMD<ref>Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-92. doi: 10.1159/000047881.</ref>. TMD occurs 1.5 to 2.5 times more frequently in women than in men<ref>Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-92. doi: 10.1159/000047881.</ref>.


Diversi approcci terapeutici sono in fase di studio per la gestione dei TMD, con l'obiettivo di alleviare il dolore e migliorare la funzionalità della mandibola<ref>Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res 2018;11:571-87. doi: 10.2147/JPR.S127950</ref>. Sebbene siano disponibili metodi chirurgici e non chirurgici per trattare i TMD, il trattamento conservativo è l'opzione iniziale e primaria<ref>Abouelhuda AM, Khalifa AK, Kim YK, Hegazy SA. Non-invasive different modalities of treatment for temporomandibular disorders: review of literature. J Korean Assoc Oral Maxillofac Surg 2018;44:43-51. doi: 10.5125/jkaoms.2018.44.2.43</ref>. Le terapie farmacologiche comprendono l'uso di farmaci antinfiammatori non steroidei (FANS), antidepressivi e miorilassanti. Un'altra componente del trattamento consiste in tecniche di terapia occlusale e fisica, come la laserterapia a basso livello (LLLT) e la Stimolazione Elettrica Transcutanea del nervo trigeminale (TENS).<ref>Rezazadeh F, Hajian K, Shahidi S, Piroozi S. Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation and Low-Level Laser Therapy on Drug-Resistant Temporomandibular Disorders. J Dent (Shiraz) 2017;18:187-92</ref>
Various therapeutic approaches are being studied for managing TMD, aiming to relieve pain and improve jaw function<ref>Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res 2018;11:571-87. doi: 10.2147/JPR.S127950.</ref>. Although surgical and non-surgical methods are available for treating TMD, conservative treatment is the initial and primary option<ref>Abouelhuda AM, Khalifa AK, Kim YK, Hegazy SA. Non-invasive different modalities of treatment for temporomandibular disorders: review of literature. J Korean Assoc Oral Maxillofac Surg 2018;44:43-51. doi: 10.5125/jkaoms.2018.44.2.43.</ref>. Pharmacological therapies include the use of nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, and muscle relaxants. Another treatment component consists of occlusal and physical therapy techniques, such as low-level laser therapy (LLLT) and Transcutaneous Electrical Nerve Stimulation of the trigeminal nerve (TENS)<ref>Rezazadeh F, Hajian K, Shahidi S, Piroozi S. Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation and Low-Level Laser Therapy on Drug-Resistant Temporomandibular Disorders. J Dent (Shiraz) 2017;18:187-92.</ref>.[[File:Myomonitor.jpg|thumb|400x400px|'''Figura 1:''' Disposizione degli elettrodi registranti sul muscolo Temporale e massetere. L'elettrodo stimolante in regione della Articolazione Temporomandibolare.]]TENS (Figure 1) has gained recognition as a non-invasive and drug-free technique for pain management in TMD. It involves applying


La 'TENS' ha acquisito riconoscimento come tecnica non invasiva e priva di farmaci per la gestione del dolore nei TMD. Consiste nell'applicazione di correnti elettriche a bassa frequenza sulla pelle tramite elettrodi di superficie<ref>Shanavas M, Chatra L, Shenai P, Rao PK, Jagathish V, Kumar SP, et al. Transcutaneous electrical nerve stimulation therapy: An adjuvant pain controlling modality in TMD patients - A clinical study. Dent Res J (Isfahan) 2014;11:676-9</ref><ref>Martimbianco ALC, Porfírio GJ, Pacheco RL, Torloni MR, Riera R. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain. Cochrane Database Syst Rev 2019;12:CD011927. doi: 10.1002/14651858.CD011927.pub2</ref>. Queste correnti stimolano '''i nervi sensoriali''' e '''modulano i segnali del dolore''' trasmessi al sistema nervoso centrale (CNS), alterando la percezione del dolore. La TENS è utilizzata nei pazienti con TMD per mirare ai muscoli e ai nervi circostanti la TMJ, promuovendo il rilassamento muscolare, riducendo gli '''spasmi muscolari''' e alleviando il disagio<ref>Hsieh YL, Yang CC, Yang NP. Ultra-Low Frequency Transcutaneous Electrical Nerve Stimulation on Pain Modulation in a Rat Model with Myogenous Temporomandibular Dysfunction. Int J Mol Sci 2021;22:9906. doi: 10.3390/ijms22189906</ref>.
low-frequency electrical currents to the skin through surface electrodes<ref>Shanavas M, Chatra L, Shenai P, Rao PK, Jagathish V, Kumar SP, et al. Transcutaneous electrical nerve stimulation therapy: An adjuvant pain controlling modality in TMD patients - A clinical study. Dent Res J (Isfahan) 2014;11:676-9.</ref><ref>Martimbianco ALC, Porfírio GJ, Pacheco RL, Torloni MR, Riera R. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain. Cochrane Database Syst Rev 2019;12:CD011927. doi: 10.1002/14651858.CD011927.pub2.</ref>. These currents stimulate sensory nerves and modulate pain signals transmitted to the central nervous system (CNS), altering pain perception. TENS is used in TMD patients to target muscles and nerves surrounding the TMJ, promoting muscle relaxation, reducing muscle spasms, and relieving discomfort.<ref>Hsieh YL, Yang CC, Yang NP. Ultra-Low Frequency Transcutaneous Electrical Nerve Stimulation on Pain Modulation in a Rat Model with Myogenous Temporomandibular Dysfunction. Int J Mol Sci 2021;22:9906. doi: 10.3390/ijms22189906.</ref><ref>Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res 2018;11:571-87. doi: 10.2147/JPR.S127950.</ref>


Comprendere l'efficacia comparativa della TENS e degli analgesici nel trattamento dei TMD è cruciale per i professionisti sanitari<ref>Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res 2018;11:571-87. doi: 10.2147/JPR.S127950</ref>. Identificando i vantaggi e gli svantaggi di entrambi gli approcci, i clinici possono selezionare l'opzione di trattamento più appropriata per ciascun paziente<ref>Beutler LE, Someah K, Kimpara S, Miller K. Selecting the most appropriate treatment for each patient. Int J Clin Health Psychol 2016;16:99-10. doi: 10.1016/j.ijchp.2015.08.001</ref>.  
By comparing the advantages and disadvantages of different approaches, clinicians can select the most appropriate treatment option for each patient<ref>Beutler LE, Someah K, Kimpara S, Miller K. Selecting the most appropriate treatment for each patient. Int J Clin Health Psychol 2016;16:99-10. doi: 10.1016/j.ijchp.2015.08.001.</ref>.


Confrontando la TENS con altre modalità di trattamento, studi hanno valutato la sua efficacia, sicurezza e praticabilità nel ridurre il dolore e '''migliorare la funzione''' masticatoria nei pazienti con TMD<ref>Chellappa D, Thirupathy M. Comparative efficacy of low-Level laser and TENS in the symptomatic relief of temporomandibular joint disorders: A randomized clinical trial. Indian J Dent Res 2020;31:42-7. doi: 10.4103/ijdr.IJDR_735_18</ref>.  
Studies have evaluated the efficacy, safety, and feasibility of TENS in reducing pain and improving masticatory function in TMD patients<ref>Chellappa D, Thirupathy M. Comparative efficacy of low-Level laser and TENS in the symptomatic relief of temporomandibular joint disorders: A randomized clinical trial. Indian J Dent Res 2020;31:42-7. doi: 10.4103/ijdr.IJDR_735_18.</ref>.
Despite the growing recognition of TENS as a non-invasive approach for managing TMD, there is still a lack of a comprehensive comparative analysis of its effectiveness against commonly used analgesics for TMD treatment<ref>Wu M, Cai J, Yu Y, Hu S, Wang Y, Wu M. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective. Front Pharmacol 2021;11:596099. doi: 10.3389/fphar.2020.596099.</ref>. Therefore, we found it interesting to extract conclusions from specific articles and correlate them with our own interpretations, which will generate topics for further discussion. Let’s see which ones:


Nonostante il crescente riconoscimento della TENS come approccio non invasivo per la gestione dei TMD, manca un'analisi comparativa completa della sua efficacia rispetto agli analgesici comunemente usati nel trattamento dei TMD<ref>Wu M, Cai J, Yu Y, Hu S, Wang Y, Wu M. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective. Front Pharmacol 2021;11:596099. doi: 10.3389/fphar.2020.596099</ref>.
*Rémi Esclassan<ref>Rémi Esclassan 1, Anaïs Rumerio 2, Paul Monsarrat 1 2, Jean Claude Combadazou 1 2, Jean Champion 1 2, Florent Destruhaut 1 2, Christophe Ghrenassia 1 2. Optimal duration of ultra low frequency-transcutaneous electrical nerve stimulation (ULF-TENS) therapy for muscular relaxation in neuromuscular occlusion: A preliminary clinical study. Cranio. 2017 May;35(3):175-179. doi: 10.1080/08869634.2016.1171479. Epub 2016 Apr 8.</ref> (2017), whose primary goal was to determine the duration of ultra-low frequency TENS (ULF-TENS) application necessary to achieve sufficient relaxation of the masticatory muscles. Overall, the results suggest that an optimal ULF-TENS application should last 40 minutes to achieve sufficient muscle relaxation in both patients with masticatory system disorders and healthy subjects—a duration that aligns with everyday clinical practice.


In letteratura possiamo evidenziare alcuni articoli degni di nota come quelli di:
<blockquote>
The question that arises is when and why a healthy subject’s muscle would be in a non-relaxed state, requiring TENS to achieve relaxation.
</blockquote>


*Rémi Esclassan<ref>Rémi Esclassan 1, Anaïs Rumerio 2, Paul Monsarrat 1 2, Jean Claude Combadazou 1 2, Jean Champion 1 2, Florent Destruhaut 1 2, Christophe Ghrenassia 1 2. Optimal duration of ultra low frequency-transcutaneous electrical nerve stimulation (ULF-TENS) therapy for muscular relaxation in neuromuscular occlusion: A preliminary clinical study. Cranio. . 2017 May;35(3):175-179.
* Rafaella Mariana Fontes de Bragança<ref>Rafaella Mariana Fontes de Bragança 1, Carolina Almeida Rodrigues 1, Melissa Oliveira Melchior 1, Laís Valencise Magri 1, Marcelo Oliveira Mazzetto 1. Ultra-low frequency transcutaneous electric nerve stimulation does not affect the centric relation registration. Cranio. 2018 Jan;36(1):19-28. doi: 10.1080/08869634.2016.1278107. Epub 2017 Jan 27.</ref> (2018), whose objective was to evaluate the influence of ULF-TENS on mandibular condyle displacement and the repeatability of centric relation (CR) registration. ULF-TENS did not affect total condylar displacement, regardless of the CR registration technique used. The 'bimanual' technique showed improvement in repeatability after ULF-TENS use.
 
doi: 10.1080/08869634.2016.1171479. Epub 2016 Apr 8.
</ref> del 2017 il cui obiettivo principale è stato quello di  determinare la durata dell'applicazione della stimolazione elettrica transcutanea a frequenza ultra-bassa (ULF-TENS) necessaria per ottenere un sufficiente '''rilassamento dei muscoli masticatori'''. Nel complesso, i risultati suggeriscono che un'applicazione ideale di ULF-TENS dovrebbe durare 40 minuti per ottenere un rilassamento muscolare sufficiente sia nei pazienti con disturbi del sistema masticatorio '''sia nei soggetti sani''', una durata che risulta coerente con la pratica clinica quotidiana.


<blockquote>
<blockquote>
La perplessità che sorge è capire quando e perchè un muscolo di un soggetto sano debba essere in una condizione di non rilassamento ed ottenerlo soltanto dopo TENS. Questo è il primo evidente fenomeno non ben chiaro che balza agli occhi e cioè la condizione di 'Tono muscolare'</blockquote>  
The question raised by reading this article is why TENS would improve the repeatability of the bimanual centric relation technique—perhaps the continuity of afferent stimuli to mesencephalic nuclei leads to a sort of loss in the stereognostic effect of the mandible? If so, we should understand the neurophysiological function of TENS both peripherally and centrally, which is no easy task.
</blockquote>


*Rafaella Mariana Fontes de Bragança<ref>Rafaella Mariana Fontes de Bragança 1, Carolina Almeida Rodrigues 1, Melissa Oliveira Melchior 1, Laís Valencise Magri 1, Marcelo Oliveira Mazzetto 1. Ultra-low frequency transcutaneous electric nerve stimulation does not affect the centric relation registration. Cranio. . 2018 Jan;36(1):19-28.
*Yuanxiu Zhang<ref>Yuanxiu Zhang 1 2 3 4, Jinglu Zhang 1 3, Lin Wang 1 2 3, Kelun Wang 3 5, Peter Svensson 4 6 7. Effect of transcutaneous electrical nerve stimulation on jaw movement-evoked pain in patients with TMJ disc displacement without reduction and healthy controls. Acta Odontol Scand. 2020 May;78(4):309-320. doi: 10.1080/00016357.2019.1707868. Epub 2019 Dec 26.</ref> (2020), whose goal was to assess the effect of TENS on pain and movement patterns after repeated mandibular movements in patients with temporomandibular joints (TMJ) pain and disc displacement without reduction (DDwoR) and to compare them with healthy volunteers. The results indicated that movement-evoked pain was spontaneously reduced by TENS in patients with painful TMJ and DDwoR. Interestingly, TENS reduced movement-evoked pain and improved mandibular motor function during repeated movements. These findings could have implications for TENS treatment in patients with painful TMJ and DDwoR.


doi: 10.1080/08869634.2016.1278107. Epub 2017 Jan 27.
</ref>del 2018 il cui obiettivo è stato quello di valutare l'influenza della ULF-TENS sullo spostamento del condilo mandibolare e sulla ripetibilità della registrazione della relazione centrica (CR)  La ULF-TENS non ha influenzato lo spostamento totale del condilo, indipendentemente dalla tecnica di registrazione della CR utilizzata La tecnica 'bimanuale' ha mostrato un miglioramento nella ripetibilità dopo l'uso della ULF-TENS.
<blockquote>
<blockquote>
La perplessità che sorge dalla lettura di questo articolo è perchè mai la TENS debba migliorare la ripetibilità della manovra centrica bimanuale forse la continui stimoli afferenti ai nuclei mesencefalici determinano una sorta di perdita delle stereognosica della mandbola. Allora dovremmo capire il funzionamento della TENs a livello neurofisiologico sia periferico che centrale, cosa che nei prossimi capitoli affronteremo. </blockquote>
This assertion, moreover, was made by Peter Svensson (co-author of the article), an active collaborator in the RDC Consortium<ref>Eric Schiffman, Richard Ohrbach, Edmond Truelove, John Look, Gary Anderson, Jean-Paul Goulet, Thomas List, Peter Svensson, Yoly Gonzalez, Frank Lobbezoo, Ambra Michelotti, Sharon L Brooks, Werner Ceusters, Mark Drangsholt, Dominik Ettlin, Charly Gaul, Louis J Goldberg, Jennifer A Haythornthwaite, Lars Hollender, Rigmor Jensen, Mike T John, Antoon De Laat, Reny de Leeuw, William Maixner, Marylee van der Meulen, Greg M Murray, Donald R Nixdorf, Sandro Palla, Arne Petersson, Paul Pionchon, Barry Smith, Corine M Visscher, Joanna Zakrzewska, Samuel F Dworkin; International RDC/TMD Consortium Network, International Association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group†. J.Oral Facial Pain Headache. 2014 Winter; 28(1):6-27. doi: 10.11607/jop.1151.</ref> and a strong supporter of excluding TENS as a clinical procedure, in 2014, prior to the release of the referenced article. Again, the uncertainty focuses on the mechanism of action—whether it's a form of 'Gate Control' or purely a phenomenon related to trigeminal neuromotor mechanisms?
</blockquote>


* Yuanxiu Zhang<ref>Yuanxiu Zhang 1 2 3 4, Jinglu Zhang 1 3, Lin Wang 1 2 3, Kelun Wang 3 5, Peter Svensson 4 6 7. Effect of transcutaneous electrical nerve stimulation on jaw movement-evoked pain in patients with TMJ disc displacement without reduction and healthy controls. Acta Odontol Scand. . 2020 May;78(4):309-320.
*Syeda Mahnoor Fatima<ref>Syeda Mahnoor Fatima, Tooba Zahoor, Ramsha Nawaz, Ahmed Tanveer, Syeda Soveba Zaidi. Role of transcutaneous electrical nerve stimulation in temporomandibular joint disorders. J Pak Med Assoc. 2024 Sep;74(9):1645-1648. doi: 10.47391/JPMA.10874.</ref> (2024) presented alarming epidemiological data, showing that 60% of the general population suffer from at least one TMD symptom, and 48% of TMD patients exhibited clinical symptoms, including muscle tension and difficulty opening the mouth<ref>Ryan J, Akhter R, Hassan N, Hilton G, Wickham J, Ibarag S. Epidemiology of Temporomandibular Disorder in the General Population: a systematic review. Adv Dent & Oral Health 2019;10:555787. doi: 10.19080/ADOH.2019.10.555787.</ref>. One subgroup treated with microcurrent nerve stimulation (MENS) showed significant improvement in VAS scores<ref>Saranya B, Ahmed J, Shenoy N, Ongole R, Sujir N, Natarajan S. Comparison of Transcutaneous Electric Nerve Stimulation (TENS) and Microcurrent Nerve Stimulation (MENS) in the Management of Masticatory Muscle Pain: A Comparative Study. Pain Res Manag 2019;2019:8291624. doi: 10.1155/2019/8291624.</ref>.
 
doi: 10.1080/00016357.2019.1707868. Epub 2019 Dec 26.
</ref> del 2020 il cui obiettivo è stato quello di valutare l'effetto della TENS sul dolore e sui modelli di movimento dopo movimenti ripetuti della mandibola in pazienti con articolazioni temporomandibolari (TMJ) dolorose e spostamento del disco senza riduzione (DDwoR), e confrontarlii con volontari sani. I risultati hanno indicato che il dolore evocato dai movimenti è stato ridotto spontaneamente o dal sTENS nei pazienti con dolore alla TMJ con DDwoR e, in modo interessante, che la TENS potrebbe attenuare il dolore evocato dai movimenti e migliorare la funzione motoria della mandibola durante i movimenti ripetuti. I risultati potrebbero avere implicazioni per il trattamento con TENS nei pazienti con dolore alla TMJ con DDwoR.


<blockquote>
<blockquote>
Anche qui la perplessità si focalizza sul meccanismo d'azione e cioè è una sorta di fenomeno di 'gate Control' oppure esclusivamente motorio? </blockquote>
The startling statistic of 60% of the population experiencing TMJ Disorders with muscle stiffness or reduced mouth opening prompts only two questions: Of the world’s 8 billion people, are at least 4.8 billion suffering from TMD? Perhaps we are losing control of the data, or there is a fundamental error in clinical assessment. Are we sure we have the knowledge and valid tools to interpret the TMD condition in patients? Based on the previously discussed chapters in the 'Normal Science' section, it doesn’t seem so. Nevertheless, we will delve deeper into the topic to determine if there is an epistemological anomaly.
 
</blockquote>
*Syeda Mahnoor Fatima<ref>Syeda Mahnoor Fatima, Tooba Zahoor, Ramsha Nawaz, Ahmed Tanveer, Syeda Soveba Zaidi. Role of transcutaneous electrical nerve stimulation in temporomandibular joint disorders. J Pak Med Assoc. . 2024 Sep;74(9):1645-1648. doi: 10.47391/JPMA.10874.
</ref>molto recente del 2024 che partivano da un dato epidemiologico sconcertante e cioè che i loro risultati attuali erano coerenti con uno studio secondo cui il 5-60% della popolazione generale soffre di almeno uno dei segni del TMD. Inoltre, il 48% dei pazienti con TMD ha mostrato sintomi clinici, tra cui tenerezza muscolare e difficoltà ad aprire la bocca<ref>Ryan J, Akhter R, Hassan N, Hilton G, Wickham J, Ibarag S. Epidemiology of Temporomandibular Disorder in the General Population: a systematic review. Adv Dent & Oral Health 2019;10:555787. DOI: 10.19080/ADOH.2019.10.555787</ref>. Uno dei sottogruppi trattati con stimolazione nervosa elettrica a microcorrente (MENS) ha dimostrato un significativo miglioramento nei punteggi VAS.<ref>Saranya B, Ahmed J, Shenoy N, Ongole R, Sujir N, Natarajan S. Comparison of Transcutaneous Electric Nerve Stimulation (TENS) and Microcurrent Nerve Stimulation (MENS) in the Management of Masticatory Muscle Pain: A Comparative Study. Pain Res Manag 2019;2019:8291624. doi: 10.1155/2019/8291624</ref>
 
<blockquote>Qui la perplessità sta nel dato sconcertante del 60% dii popolazione che accusa Disturbi della ATM con rigidità muscolare e/o ridotta apertura della bocca, I casi in questo caso non sono infini ma solo due e cioè che sull'intera popolazione mondiale di 8 miliardi di persone  4 mliardi e 800 milioni di persone soffrono di Disordini Temporomandibolari? Forse stiamo perdendo il controllo del dato clinico e della valutazione clinica. Siamo sicuri di avere conoscenza e mezzi validi per interpretare lo stato di malattia di un soggetto TMDs? Dai capitoli precedntemente esposti nella sezione 'Scienza Normale' non sembra comunque approfondiamo il tema per capire semmai esista una anomalia nel sistema.</blockquote>Ancor più sconcertante è che un recentissimo articolo di Taseef Hasan Farook<ref>Taseef Hasan Farook, Tashreque Mohammed Haq, Lameesa Ramees, James Dudley. Predictive modelling of freeway space utilising clinical history, normalised muscle activity, dental occlusion, and mandibular movement analysis. SCI Rep</ref>pubblicato nel 2024 sulla rivista Scientific reports facente parte della prestigioso Nature Publishing Group arriva alle seguenti asserzioni.
 
IIl "freeway space" è la distanza tra le arcate dentarie in posizione di riposo<ref>Pleasure, M. A. Correct vertical dimension and freeway space. J Am Dental Assoc 43, 160–163 (1951)</ref>. È un parametro essenziale in protesi dentale, influenzando occlusione e dimensione verticale<ref>Pleasure, M. A. Correct vertical dimension and freeway space. J Am Dental Assoc 43, 160–163 (1951)</ref>. Un adeguato spazio interocclusale garantisce la stabilità protesica e previene disturbi temporomandibolari (TMD) e affaticamento muscolare<ref>Farook, T. H., Rashid, F., Alam, M. K. & Dudley, J. Variables influencing the device-dependent approaches in digitally analysing jaw movement—a systematic review. Clin. Oral. Investig. 27(2), 489–504 (2022)</ref>. Il TENS (Stimolazione Nervosa Elettrica Transcutanea) è utilizzato per rilassare i muscoli e valutare la corretta dimensione verticale in relazione allo spazio interocclusale<ref>Snyder, B., TENS and the treatment of TMJ dysfunction. J Prosthet Dent 45, 335–338 (1981)</ref>. Tecnologie recenti, come il deep learning, riducono la soggettività nelle misurazioni, standardizzando l'approccio clinico<ref>Farook, T. H. & Dudley, J. Automation and deep (machine) learning in temporomandibular joint disorder radiomics. A Systematic review. J. Oral. Rehabil. 50(6), 501–521 (2023)</ref>.
 
Anche in questo caso l’asserzione riportata dagli autore fa sorgere un ulteriore dubbio quello della corretta dimensione verticale come dire se non esegui la TENS per 40’ la dimensione verticale determinata risulterà alterata e probabilmente non fisiologica. 


A nostro parere tutte queste disquisizioni intellettualmente interessanti e stimolanti da un punto di vista clinico conducono tutte ad un comune denominatore che è in ordine prima lo ‘ free way space’ e dopo lo ‘ Tono muscolare’, temi che tratteremo nei due prossimi capitoli.  
Even more shocking is a very recent article by Taseef Hasan Farook<ref>Taseef Hasan Farook, Tashreque Mohammed Haq, Lameesa Ramees, James Dudley. Predictive modelling of freeway space utilising clinical history, normalised muscle activity, dental occlusion, and mandibular movement analysis. SCI Rep.</ref>, published in 2024 in Scientific Reports, part of the prestigious Nature Publishing Group, which concludes with the following assertions.


The "freeway space" is the distance between the dental arches at rest<ref>Pleasure, M. A. Correct vertical dimension and freeway space. J Am Dental Assoc 43, 160–163 (1951).</ref>. It is a critical parameter in dental prosthetics, influencing occlusion and vertical dimension<ref>Pleasure, M. A. Correct vertical dimension and freeway space. J Am Dental Assoc 43, 160–163 (1951).</ref>. Adequate freeway space ensures prosthetic stability and prevents temporomandibular disorders (TMD) and muscle fatigue<ref>Farook, T. H., Rashid, F., Alam, M. K. & Dudley, J. Variables influencing the device-dependent approaches in digitally analysing jaw movement—a systematic review. Clin. Oral. Investig. 27(2), 489–504 (2022).</ref>. TENS (Transcutaneous Electrical Nerve Stimulation) is used to relax the muscles and assess the correct vertical dimension in relation to the freeway space<ref>Snyder, B., TENS and the treatment of TMJ dysfunction. J Prosthet Dent 45, 335–338 (1981).</ref><ref>Farook, T. H. & Dudley, J. Automation and deep (machine) learning in temporomandibular joint disorder radiomics. A Systematic review. J. Oral. Rehabil. 50(6), 501–521 (2023).</ref>.


[[File:Question 2.jpg|left|150x150px]]
{{q2|So, if TENS is not performed, could the vertical dimension even in healthy individuals be incorrect? |... in our opinion, all these intellectually interesting and scientifically stimulating discussions lead to a common denominator: 'Muscle tone,' a topic we will address in the next two chapters, correlating it with the 'Freeway space.'}}




{{Bib}}
{{Bib}}

Revision as of 16:47, 21 October 2024

Transcutaneous Electric Nerve Stimulation

 

Masticationpedia
Article by  Gianni Frisardi

 

Introduction

In this chapter, we consider another highly debated topic: Transcutaneous Electrical Nerve Stimulation (TENS), on which there is still no unanimous opinion within the International Scientific Community. This premise is confirmed by the fact that, although the Research Diagnostic Criteria (RDC) have categorically invalidated the clinical procedure in diagnosing patients with Temporomandibular Disorders, the procedure is still considered valid. It continues to be discussed, articles are published, and it is still practiced. This inconsistency is demonstrated by scientific papers in the literature with intermediate and ambiguous conclusions, which generate only questions without providing valid answers.

The RDC has clinically deemed the TENS procedure invalid based on the freeway space and myocentric trajectory, both as diagnostic elements for Temporomandibular Disorders (TMD) and as part of masticatory prosthetic rehabilitation treatment. As can be seen from the specific section of Table 1 presented in the chapter Research Diagnostic Criteria (RDC), it is clear that both freeway space and TENS trajectory were excluded due to a low predictive value (PPV: 0.17). While this might be true, it is essential to delve into the technical and methodological details to understand the rationale behind this decision. For this reason, we will briefly but thoroughly describe the TENS method to better understand its weaknesses and strengths.

Table 1: TMD diagnostic methodologies analyzed and excluded by the DRC due to lack of scientific validation
Diagnostic Tests Cutoff Sensitivity Specificity PPV
Electrical stimulation methods
Free rest space before stimulation (Cooper and Rabuzzi 1984)[1] 0.75-2.0 mm 0.42 0.62 0.17
Free rest space after electrical stimulation (Cooper and Rabuzzi 1984)[1] 0.75-2.0 mm 0.76 0.19 0.11
Closure trajectory before and after electrical stimulation (Cooper and Rabuzzi 1984)[1] Undefined 0.75 0.27 0.12
Cutoff: Parameters and significance limits used to separate healthy from sick subjects for each reported test.Sensitivity: The ability of the specified test to identify truly sick subjects in a mixed sample of healthy and sick subjects.Specificity: The ability of the specified test to identify healthy subjects in a mixed sample of healthy and sick subjects.Positive Predictive Value (PPV): The ratio of the specified test’s ability to identify truly sick patients to the total sick population in a mixed sample of healthy and sick subjects.

TENS and Temporomandibular Disorders

The temporomandibular joint (TMJ) is a hinge joint with biarticular properties, enabling the complex movements required for chewing[2]. Temporomandibular disorder (TMD) occurs when the TMJ and associated anatomical structures are affected[3][4]. Approximately 25% of individuals worldwide show signs or symptoms of TMD[5]. TMD occurs 1.5 to 2.5 times more frequently in women than in men[6].

Various therapeutic approaches are being studied for managing TMD, aiming to relieve pain and improve jaw function[7]. Although surgical and non-surgical methods are available for treating TMD, conservative treatment is the initial and primary option[8]. Pharmacological therapies include the use of nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, and muscle relaxants. Another treatment component consists of occlusal and physical therapy techniques, such as low-level laser therapy (LLLT) and Transcutaneous Electrical Nerve Stimulation of the trigeminal nerve (TENS)[9].

Figura 1: Disposizione degli elettrodi registranti sul muscolo Temporale e massetere. L'elettrodo stimolante in regione della Articolazione Temporomandibolare.

TENS (Figure 1) has gained recognition as a non-invasive and drug-free technique for pain management in TMD. It involves applying

low-frequency electrical currents to the skin through surface electrodes[10][11]. These currents stimulate sensory nerves and modulate pain signals transmitted to the central nervous system (CNS), altering pain perception. TENS is used in TMD patients to target muscles and nerves surrounding the TMJ, promoting muscle relaxation, reducing muscle spasms, and relieving discomfort.[12][13]

By comparing the advantages and disadvantages of different approaches, clinicians can select the most appropriate treatment option for each patient[14].

Studies have evaluated the efficacy, safety, and feasibility of TENS in reducing pain and improving masticatory function in TMD patients[15]. Despite the growing recognition of TENS as a non-invasive approach for managing TMD, there is still a lack of a comprehensive comparative analysis of its effectiveness against commonly used analgesics for TMD treatment[16]. Therefore, we found it interesting to extract conclusions from specific articles and correlate them with our own interpretations, which will generate topics for further discussion. Let’s see which ones:

  • Rémi Esclassan[17] (2017), whose primary goal was to determine the duration of ultra-low frequency TENS (ULF-TENS) application necessary to achieve sufficient relaxation of the masticatory muscles. Overall, the results suggest that an optimal ULF-TENS application should last 40 minutes to achieve sufficient muscle relaxation in both patients with masticatory system disorders and healthy subjects—a duration that aligns with everyday clinical practice.

The question that arises is when and why a healthy subject’s muscle would be in a non-relaxed state, requiring TENS to achieve relaxation.

  • Rafaella Mariana Fontes de Bragança[18] (2018), whose objective was to evaluate the influence of ULF-TENS on mandibular condyle displacement and the repeatability of centric relation (CR) registration. ULF-TENS did not affect total condylar displacement, regardless of the CR registration technique used. The 'bimanual' technique showed improvement in repeatability after ULF-TENS use.

The question raised by reading this article is why TENS would improve the repeatability of the bimanual centric relation technique—perhaps the continuity of afferent stimuli to mesencephalic nuclei leads to a sort of loss in the stereognostic effect of the mandible? If so, we should understand the neurophysiological function of TENS both peripherally and centrally, which is no easy task.

  • Yuanxiu Zhang[19] (2020), whose goal was to assess the effect of TENS on pain and movement patterns after repeated mandibular movements in patients with temporomandibular joints (TMJ) pain and disc displacement without reduction (DDwoR) and to compare them with healthy volunteers. The results indicated that movement-evoked pain was spontaneously reduced by TENS in patients with painful TMJ and DDwoR. Interestingly, TENS reduced movement-evoked pain and improved mandibular motor function during repeated movements. These findings could have implications for TENS treatment in patients with painful TMJ and DDwoR.

This assertion, moreover, was made by Peter Svensson (co-author of the article), an active collaborator in the RDC Consortium[20] and a strong supporter of excluding TENS as a clinical procedure, in 2014, prior to the release of the referenced article. Again, the uncertainty focuses on the mechanism of action—whether it's a form of 'Gate Control' or purely a phenomenon related to trigeminal neuromotor mechanisms?

  • Syeda Mahnoor Fatima[21] (2024) presented alarming epidemiological data, showing that 60% of the general population suffer from at least one TMD symptom, and 48% of TMD patients exhibited clinical symptoms, including muscle tension and difficulty opening the mouth[22]. One subgroup treated with microcurrent nerve stimulation (MENS) showed significant improvement in VAS scores[23].

The startling statistic of 60% of the population experiencing TMJ Disorders with muscle stiffness or reduced mouth opening prompts only two questions: Of the world’s 8 billion people, are at least 4.8 billion suffering from TMD? Perhaps we are losing control of the data, or there is a fundamental error in clinical assessment. Are we sure we have the knowledge and valid tools to interpret the TMD condition in patients? Based on the previously discussed chapters in the 'Normal Science' section, it doesn’t seem so. Nevertheless, we will delve deeper into the topic to determine if there is an epistemological anomaly.

Even more shocking is a very recent article by Taseef Hasan Farook[24], published in 2024 in Scientific Reports, part of the prestigious Nature Publishing Group, which concludes with the following assertions.

The "freeway space" is the distance between the dental arches at rest[25]. It is a critical parameter in dental prosthetics, influencing occlusion and vertical dimension[26]. Adequate freeway space ensures prosthetic stability and prevents temporomandibular disorders (TMD) and muscle fatigue[27]. TENS (Transcutaneous Electrical Nerve Stimulation) is used to relax the muscles and assess the correct vertical dimension in relation to the freeway space[28][29].

Question 2.jpg
«So, if TENS is not performed, could the vertical dimension even in healthy individuals be incorrect?»
(... in our opinion, all these intellectually interesting and scientifically stimulating discussions lead to a common denominator: 'Muscle tone,' a topic we will address in the next two chapters, correlating it with the 'Freeway space.')


Bibliography & references
  1. 1.0 1.1 1.2 BC Cooper, D D Rabuzzi. Myofacial pain dysfunction syndrome: a clinical study of asymptomatic subjects. Laryngoscope. 1984 Jan;94(1):68-75. doi: 10.1002/lary.5540940116.
  2. Okoje VN, Aladelusi TO, Abimbola TA. Managing temporomandibular joint dislocation in ibadan: a review of 11 cases. Ann Ib Postgrad Med 2017;15:96-10.
  3. Maini K, Dua A. Temporomandibular Syndrome. Treasure Island, FL: StatPearls Publishing; 2024.
  4. Murphy MK, MacBarb RF, Wong ME, Athanasiou KA. Temporomandibular disorders: a review of etiology, clinical management, and tissue engineering strategies. Int J Oral Maxillofac Implants 2013;28:e393-414. doi: 10.11607/jomi.te20.
  5. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-92. doi: 10.1159/000047881.
  6. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-92. doi: 10.1159/000047881.
  7. Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res 2018;11:571-87. doi: 10.2147/JPR.S127950.
  8. Abouelhuda AM, Khalifa AK, Kim YK, Hegazy SA. Non-invasive different modalities of treatment for temporomandibular disorders: review of literature. J Korean Assoc Oral Maxillofac Surg 2018;44:43-51. doi: 10.5125/jkaoms.2018.44.2.43.
  9. Rezazadeh F, Hajian K, Shahidi S, Piroozi S. Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation and Low-Level Laser Therapy on Drug-Resistant Temporomandibular Disorders. J Dent (Shiraz) 2017;18:187-92.
  10. Shanavas M, Chatra L, Shenai P, Rao PK, Jagathish V, Kumar SP, et al. Transcutaneous electrical nerve stimulation therapy: An adjuvant pain controlling modality in TMD patients - A clinical study. Dent Res J (Isfahan) 2014;11:676-9.
  11. Martimbianco ALC, Porfírio GJ, Pacheco RL, Torloni MR, Riera R. Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain. Cochrane Database Syst Rev 2019;12:CD011927. doi: 10.1002/14651858.CD011927.pub2.
  12. Hsieh YL, Yang CC, Yang NP. Ultra-Low Frequency Transcutaneous Electrical Nerve Stimulation on Pain Modulation in a Rat Model with Myogenous Temporomandibular Dysfunction. Int J Mol Sci 2021;22:9906. doi: 10.3390/ijms22189906.
  13. Gil-Martínez A, Paris-Alemany A, López-de-Uralde-Villanueva I, La Touche R. Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions. J Pain Res 2018;11:571-87. doi: 10.2147/JPR.S127950.
  14. Beutler LE, Someah K, Kimpara S, Miller K. Selecting the most appropriate treatment for each patient. Int J Clin Health Psychol 2016;16:99-10. doi: 10.1016/j.ijchp.2015.08.001.
  15. Chellappa D, Thirupathy M. Comparative efficacy of low-Level laser and TENS in the symptomatic relief of temporomandibular joint disorders: A randomized clinical trial. Indian J Dent Res 2020;31:42-7. doi: 10.4103/ijdr.IJDR_735_18.
  16. Wu M, Cai J, Yu Y, Hu S, Wang Y, Wu M. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective. Front Pharmacol 2021;11:596099. doi: 10.3389/fphar.2020.596099.
  17. Rémi Esclassan 1, Anaïs Rumerio 2, Paul Monsarrat 1 2, Jean Claude Combadazou 1 2, Jean Champion 1 2, Florent Destruhaut 1 2, Christophe Ghrenassia 1 2. Optimal duration of ultra low frequency-transcutaneous electrical nerve stimulation (ULF-TENS) therapy for muscular relaxation in neuromuscular occlusion: A preliminary clinical study. Cranio. 2017 May;35(3):175-179. doi: 10.1080/08869634.2016.1171479. Epub 2016 Apr 8.
  18. Rafaella Mariana Fontes de Bragança 1, Carolina Almeida Rodrigues 1, Melissa Oliveira Melchior 1, Laís Valencise Magri 1, Marcelo Oliveira Mazzetto 1. Ultra-low frequency transcutaneous electric nerve stimulation does not affect the centric relation registration. Cranio. 2018 Jan;36(1):19-28. doi: 10.1080/08869634.2016.1278107. Epub 2017 Jan 27.
  19. Yuanxiu Zhang 1 2 3 4, Jinglu Zhang 1 3, Lin Wang 1 2 3, Kelun Wang 3 5, Peter Svensson 4 6 7. Effect of transcutaneous electrical nerve stimulation on jaw movement-evoked pain in patients with TMJ disc displacement without reduction and healthy controls. Acta Odontol Scand. 2020 May;78(4):309-320. doi: 10.1080/00016357.2019.1707868. Epub 2019 Dec 26.
  20. Eric Schiffman, Richard Ohrbach, Edmond Truelove, John Look, Gary Anderson, Jean-Paul Goulet, Thomas List, Peter Svensson, Yoly Gonzalez, Frank Lobbezoo, Ambra Michelotti, Sharon L Brooks, Werner Ceusters, Mark Drangsholt, Dominik Ettlin, Charly Gaul, Louis J Goldberg, Jennifer A Haythornthwaite, Lars Hollender, Rigmor Jensen, Mike T John, Antoon De Laat, Reny de Leeuw, William Maixner, Marylee van der Meulen, Greg M Murray, Donald R Nixdorf, Sandro Palla, Arne Petersson, Paul Pionchon, Barry Smith, Corine M Visscher, Joanna Zakrzewska, Samuel F Dworkin; International RDC/TMD Consortium Network, International Association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group†. J.Oral Facial Pain Headache. 2014 Winter; 28(1):6-27. doi: 10.11607/jop.1151.
  21. Syeda Mahnoor Fatima, Tooba Zahoor, Ramsha Nawaz, Ahmed Tanveer, Syeda Soveba Zaidi. Role of transcutaneous electrical nerve stimulation in temporomandibular joint disorders. J Pak Med Assoc. 2024 Sep;74(9):1645-1648. doi: 10.47391/JPMA.10874.
  22. Ryan J, Akhter R, Hassan N, Hilton G, Wickham J, Ibarag S. Epidemiology of Temporomandibular Disorder in the General Population: a systematic review. Adv Dent & Oral Health 2019;10:555787. doi: 10.19080/ADOH.2019.10.555787.
  23. Saranya B, Ahmed J, Shenoy N, Ongole R, Sujir N, Natarajan S. Comparison of Transcutaneous Electric Nerve Stimulation (TENS) and Microcurrent Nerve Stimulation (MENS) in the Management of Masticatory Muscle Pain: A Comparative Study. Pain Res Manag 2019;2019:8291624. doi: 10.1155/2019/8291624.
  24. Taseef Hasan Farook, Tashreque Mohammed Haq, Lameesa Ramees, James Dudley. Predictive modelling of freeway space utilising clinical history, normalised muscle activity, dental occlusion, and mandibular movement analysis. SCI Rep.
  25. Pleasure, M. A. Correct vertical dimension and freeway space. J Am Dental Assoc 43, 160–163 (1951).
  26. Pleasure, M. A. Correct vertical dimension and freeway space. J Am Dental Assoc 43, 160–163 (1951).
  27. Farook, T. H., Rashid, F., Alam, M. K. & Dudley, J. Variables influencing the device-dependent approaches in digitally analysing jaw movement—a systematic review. Clin. Oral. Investig. 27(2), 489–504 (2022).
  28. Snyder, B., TENS and the treatment of TMJ dysfunction. J Prosthet Dent 45, 335–338 (1981).
  29. Farook, T. H. & Dudley, J. Automation and deep (machine) learning in temporomandibular joint disorder radiomics. A Systematic review. J. Oral. Rehabil. 50(6), 501–521 (2023).